Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools Publisher



Hasanzadeh A^{1, 2, 3} ; Ebadati A^{1, 2, 3} ; Dastanpour L^{1, 2, 3} ; Aref AR⁴ ; Sahandi Zangabad P⁵ ; Kalbasi A⁶ ; Dai X^{7, 8, 9} ; Mehta G^{10, 11, 12, 13, 14} ; Ghasemi A^{2, 15} ; Fatahi Y^{16, 17, 18} ; Joshi S¹⁹ ; Hamblin MR^{20, 21} ; Karimi M^{1, 2, 22, 23, 24} Show Affiliations
Source: ACS Pharmacology and Translational Science Published:2023

Abstract

Personalized medicine is a new approach toward safer and even cheaper treatments with minimal side effects and toxicity. Planning a therapy based on individual properties causes an effective result in a patient’s treatment, especially in a complex disease such as cancer. The benefits of personalized medicine include not only early diagnosis with high accuracy but also a more appropriate and effective therapeutic approach based on the unique clinical, genetic, and epigenetic features and biomarker profiles of a specific patient’s disease. In order to achieve personalized cancer therapy, understanding cancer biology plays an important role. One of the crucial applications of personalized medicine that has gained consideration more recently due to its capability in developing disease therapy is related to the field of stem cells. We review various applications of pluripotent, somatic, and cancer stem cells in personalized medicine, including targeted cancer therapy, cancer modeling, diagnostics, and drug screening. CRISPR-Cas gene-editing technology is then discussed as a state-of-the-art biotechnological advance with substantial impacts on medical and therapeutic applications. As part of this section, the role of CRISPR-Cas genome editing in recent cancer studies is reviewed as a further example of personalized medicine application. © 2023 American Chemical Society.